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CASE REPORT / OLGU SUNUMU 
Association of multiple myeloma and gastric adenocarcinoma 
Multipl miyeloma ve mide adenokanseri birlikteliği 
Cengiz Demir1, Murat Atmaca2, Eyup Tasdemir1, Servet Efe1 
1Department of Hematology and 2Internal Medicine, Faculty of Medicine, Yuzuncu Yil University, Van, Türkiye 
ABSTRACT  
Solid  tumors  associated  with  multiple  myeloma  have 
been demonstrated. However, it is a controversial subject 
whether there is a risk factor for the development of a 
secondary tumor.  Here we reported a case with multiple 
myeloma  and  gastric  adenocarcinoma.  A  77  years  old 
male patient was admitted with complaints of bone pain, 
left  leg  weakness,  weight  loss and  epigastric pain. Pa 
tient's  examination  revealed  monoclonal  gammopathy, 
lytic bone lesions and infiltration of plasma cells in bone 
marrow. Endoscopic examination revealed a mass in the 
proximal  stomach  and  pathological  examination  of  ul 
cerated mass showed gastric adenocarcinoma.  
Coexistence of these two disease entities needed to be 
explained by further large scale researches. J Clin Exp In-
vest 2011; 2(1): 110-113 
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ÖZET  
Multipl miyeloma ile solid tümör birlikteliği gösterilmi tir. 
Ancak multipl miyelomanın ikincil bir tümör geli iminde 
bir risk faktörü olup olmadığı tartı malı bir konudur. Biz 
burada multipl myeloma ve mide adenokarsinomu tanılı 
bir olgu sunduk. Olgumuz 77 ya ında erkek hasta kemik 
ağrısı, sol bacakta güçsüzlük, kilo kaybı ve epigastrik ağrı 
 ikayetleri ile ba vurdu. Hastada monoklonal gammapati, 
kemiklerde litik lezyonlar ve kemik iliğinde plazma hücre 
infiltrasyonu tespit edildi. Endoskopik incelemede mide 
nin kardiya proksimalinde kitle tespit edildi, ülsere kitle 
den alınan biyopsi örneklerinde adenokarsinom saptandı.  
Sonuç  olarak,  bu  iki  hastalık  birlikte  görülebilir.  Bu  iki 
hastalığın birlikte görülmesinin açıklaması ileri geni  çaplı 
ara tırmaların  yapılmasını  gerektirmektedir.  Klin  Deney  
Ar Derg 2011; 2(1): 110-113 
Anahtar  kelimeler:  Multipl  miyeloma,  mide 
adenokarsinomu, birliktelik 
INTRODUCTION 
Multiple myeloma presens with osteolytic bone le-
sions,  which  may  co-exist  with  renal  and  bone 
marrow  failure,  hypercalcemia  and  monoclonal 
gammopathy,  are  considered  to  be  a  neoplastic 
disorder  of  monoclonal  plasma  cells.
1  Multiple 
myeloma constitutes an   approximately %1 of ma-
lign  diseases  and  %10 of hematologic  malignan-
cies. The co-existence of solid tumors with multi-
ple myeloma has already been shown in literature; 
however  for  the  development  of  secondary  solid 
tumors, multiple myeloma should be brought under 
scrutiny and discussion about  whether it is a risk 
factor or not.
2,3,4 Disordered immunity and proce-
dures  such  as  chemotherapy  and  radiotherapy 
which  are  performed  in  multiple  myeloma  may 
contribute  to  the  development  of  secondary  can-
cers.
5 The co-existence of multiple neoplasia in a 
patient is not considered to be common, and thus 
multiple  neoplasia  were  reported  to  be  around  
%1.2 and %4.5 based on clinical studies and au-
topsy series.
6 If the diagnostic ranges of different 
malignancies are shorter than six months, they are 
called synchronized; and if they are longer than six 
months, they are called metachronized neoplasms. 
In this study, a case diagnosed with synchronized 
multiple myeloma and gastric adenocarcinoma was 
presented. C. Demir et al. Association of multiple myelome and gastric carcinoma 
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CASE  
A 77-year- old male patient referred to our clinic 
with complaints of bone pains, fatigue in left leg, 
weight loss and epigastric pains. He had a medical 
history  of  epigastric  complaints  lasting  for  six 
months, and lost fifteen kilograms of weight within 
this  period. Since  no  improvement  had been ob-
served in the complaints of the patient who was us-
ing proton pomp inhibitors for his epigastric com-
plaints and since he experienced an abrupt onset of 
fatigue and numbness in his left leg, he was admit-
ted in our clinic for further investigation.  
There was no disease history both in his and 
his family. In the physical examination the patient 
was cooperated. Cardiac and pulmonary examina-
tions  revealed  normal.  The  blood  pressure  was 
measured as 130/70 mmHg and pulse as 76/min. In 
the  bottom  examination,  there  was  sensitivity  in 
epigastrium region, being understood in palpation. 
In the neurologic examination, motor tissue force 
was 4/5 in upper extremities and 3/5 in the lower 
left  extremity;  there  was  also  hypoesthesia.  The 
motor force in the right lower extremity was nor-
mal. Laboratory analyses are shown in (Table 1).  
 
Table 1. Laboratory findings of the patient 
 
Hb (gr/dl)  13,2   AST (U/L)  19 
MCV (fl)  83  ALT (U/L)  11 
RBC (10
6/µL)  4,8  Creatinin (mg/dl)    0.86 
WBC (10
3/µL)  4.200  Calcium (mg)  8.2 
PLT (10
3/µL)  492.000  Albumin (g/dl)  3,3 
ESR (sec)  72  Globulin (gr/dl)  6,8 
Hb: Hemoglobin, MCV: Mean corpuscular volume, RBC: 
Red  blood  cell,  WBC: White  blood  cell,  PLT:  Platelet, 
AST:  Aspartate  transaminase,  ALT:  Alanine  transami-
nase, ESR: Erythrocyte sedimentation rate 
 
 
Figure  1.  Histological  apperance  of  plasma  cell  mye-
loma in the bone marrow biopsy (HE&200). 
 
Figure 2. Cytoplasmic kappa light chain positivity (kappa 
light chain&200). 
 
 
Figure 3. Loss of height of T11 vertebrae and in the pos-
terior soft tissue mass extending into the spinal canal.  C. Demir et al. Association of multiple myelome and gastric carcinoma 
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Figure  4.  Adenocarcinoma,  moderately  differentiated 
(intestinal component, Lauren classification) (HE&200) 
 
High  levels  of  globulin  and  sedimentation 
suggested multiple myeloma. Monoclonal gammo-
pathy  was  observed  in  protein  electrophoresis. 
Immunoglobulin  levels  were  found  as  thus:  IgG 
55.8 g/L, IgA 0.66 g/L, IgM 0.23 g/L. Bone mar-
row  biopsy  was  performed;  and  the  plasma  cell 
proportion in bone marrow was 45% (Figure 1-2). 
In the direct encephalography, there were lytic le-
sions.  In  the  thoracolomber  computerized  tomo-
graphy, there was a remarkable height loss in T10 
vertebra corpus and a compression fracture in the 
anterior. There were soft tissue entities involving 
vertebra  corpus  in  T9-11  and  the  posterior  ele-
ments and protruding to anterior and posterior su-
barachnoid  distance  and  remarkably  constricting 
the spinal channel (Figure 3).  
This patient who was diagnosed to have mul-
tiple myeloma underwent VAD (Vincristine, Adri-
ablastina, Dexamethasone) chemotherapy. For the 
involved vertebra, a total of 4500 cGy radiotherapy 
in a daily dose of 180 cGy and 25 fractions was 
initiated.  After  one  week  of  the  initiation  of  the 
treatment, upper gastrointestinal system endoscopy 
was conducted on the patient,  since  the  still  had 
chronic epigastric complaints. In this examination, 
partially swelled and disorganized areas in ulcer-
ated mucosa in cardia proximal under cardio eso-
phageal sphincter. In the pathologic examination of 
the biopsies taken from these areas a diagnosis of 
adenocarcinoma was made (Figure 4). 
Lymphadenopathy was detected in the medias-
ten and both of the axillaries regions in the exami-
nations  of  thorax  computerized  tomography  (the 
greatest lymphadenopathy was in a measure of 1.4 
cm).  In  the  computerized  tomography,  minimal 
liquid was observed in pelvic and around the liver. 
There was also a thickening of wall in gastro eso-
phageal junction. The patient died after a cardio-
pulmonary arrest on fifteenth day of his hospitali-
zation. Pulmonary embolus was thought to be the 
possible cause of his death. 
DISCUSSION 
The co-existence of multiple neoplasies in a patient 
is a rarely observed condition. Multiple neoplasia 
may  be  in  synchronized  or  metachronized  form. 
The reason of the co-existence of multiple neopla-
sia may be the exposure of multiple organs to car-
cinogenic  agents,  the  increased  susceptibility  of 
individuals with multiple genetic anomalies to can-
cer (p53 gene mutations and the other gene defects 
responsible for DNA restoration). Another reason 
may  be  the  carcinogenic  affect  of  therapeutic 
agents used for the first primary cancer treatment.
7-
11  
The impaired immune system and the chemo-
radiotherapy  applied  for  myeloma  treatment  are 
considered to be risk factors in the development of 
secondary cancers.5 However, a synchronic diag-
nosis of malignancies in our patient brought to the 
mind that another inducing factor. In recent years, 
publications reported the frequency of the secon-
dary primary cancers.
7  
In a study conducted by Stegeman at al. multi-
ple  myeloma  and  solid  tumor  co-existence  was 
found to be 3%.
3 In 2003 Kyle at al. reported that, 
in 1027 patients diagnosed with multiple myeloma, 
the proportion of secondary hematologic malignity 
was %0.7 and the proportion secondary solid ma-
lignity was %1.9.
12 There are also case presenta-C. Demir et al. Association of multiple myelome and gastric carcinoma 
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tions focusing on the co-existence of gastric cancer 
and multiple myeloma in Japan, which has a higher 
prevalence of gastric cancers.
13-15 Tuncer at al. re-
ported in a epidemiological study that upper gas-
trointestinal  system  cancers  in  our  region  had  a 
higher prevalence compared to the western regions 
of Turkey.
16 Based on the above premises, it would 
be much more tempting to say that further investi-
gations would be imperative in order to have an 
adequate  understanding  of  whether  the  co-
existence of these two diseases is only accidental 
or whether there is any cause and effect relation-
ship between these two diseases especially in re-
gions  in  which the  prevalence  of  gastric  cancers 
are higher.  
In our presented case, treatment for multiple 
myeloma was thought to be preliminary due to the 
fact that neurologic deficits came to the fore. Gas-
tric adenocarcinoma had been accepted as a local-
ized  disease  by  the  general  surgery  and  curative 
treatment  had  been  recommended.  However,  the 
patient  and  his  relative  had  not  given  consent. 
Therefore,  only  chemo-radiotherapy  for  multiple 
myeloma could be applied. In a study conducted 
by Sang et  al. in 2004, and carried out on three 
cases  synchronically  diagnosed  to  have  solid  tu-
mors and multiple myeloma, the treatment was di-
rected  towards  solid  tumors  since  the  prognosis 
was bad. The three cases manifested multiple mye-
loma as smoldering or stage 1. The response taken 
from the treatment initiated for these patients was 
similar to the response taken from the cases that 
had no multiple myeloma.
17 
In conclusion, further studies based on larger 
series of patients should be conducted in order to 
understand whether there is any parallel between 
the etiologies of these two diseases or any inducing 
factors underlying behind these two rare and co-
existent conditions. 
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